Gene · 7352
NIH grants1,050
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 1,050
Download this page as JSON| Grant | Title | UCP3 papers | Newest fiscal year |
|---|---|---|---|
| R01DK090625 | Integration of Feeding Time and Glucose Metabolism by the Circadian Gene Network | 1 | 2025 |
| R01DK098672 | Regulation of Mitochondrial Function by Orphan Protein Phosphatases | 1 | 2025 |
| R01DK127800 | Cross-regulation of Immunometabolism and Circadian Pathways in Obesity Pathophysiology | 1 | 2025 |
| R01DK128057 | Ensuring the cultural relevance of Dietary Guidelines diet patterns among African Americans: Increasing dietary quality and reducing type 2 diabetes risk | 1 | 2025 |
| R01DK129240 | Role of mitochondrial microRNAs (mitomiRs) in endogenous renal repair | 1 | 2025 |
| R01DK131786 | Role of SMPDL3B in obesity-associated non-alcoholic fatty liver disease | 1 | 2025 |
| R01ES026856 | Translational regulation in exposure biology - Xenobiotic-induced reprograming of tRNA modifications and selective translation of codon-biased response genes in rat and human models | 1 | 2025 |
| R01GM029090 | Myosin Gene Diversity and Function | 1 | 2025 |
| R01HD007857 | Sex Hormone Receptor Component And The Cell Genome | 1 | 2025 |
| R01HD008188 | Reproductive Hormones - Biological and Molecular Actions | 1 | 2025 |
| R01HD032443 | Dissecting the genetic underpinnings of heterochrony in limb bud initiation | 1 | 2025 |
| R01HL031197 | Mitochondrial DNA Injury is a Key Contributor to the Development of Chemical Lung Injury | 1 | 2025 |
| R01HL071158 | Acid, Succinate and Glyoxal Metabolism in Ischemia | 1 | 2025 |
| R01HL091469 | Cysteine oxidation in the heart | 1 | 2025 |
| R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 1 | 2025 |
| R01HL127349 | Genomic Analysis of Tissue and Cellular Heterogeneity in IPF | 1 | 2025 |
| R01HL137723 | Role of the unfolded protein response in pathological cardiac remodeling | 1 | 2025 |
| R01HL156951 | Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling | 1 | 2025 |
| R01NR019628 | Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention | 1 | 2025 |
| R01NS086778 | MOLECULAR MECHANISMS OF NEUROPROTECTION IN POLYGLUTAMINE-DEPENDENT DEGENERATION | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7352/grants?page=5